Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PecFent for breakthrough cancer pain
NCT00458510Phase 3Completed
- Start
- Jan 2007
- Primary completion
- Oct 2011
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of fentanyl (transdermal patch + oral transmucosal lozenge) in breakthrough cancer pain (BTcP). Started Jan 2007; status: completed.
02
Drugs
fentanyl (transdermal patch + oral transmucosal lozenge)
03
Conditions
breakthrough cancer pain (BTcP)
Beyond the preview
Go deeper on NCT00458510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00458510.